Linaclotide is FDA approved for the treatment of irritable bowel syndrome with constipation in adults; like lubiprostone, it is second-line therapy for patients whose symptoms have not responded to standard laxative therapy
If you want to change selection, open document below and click on "Move attachment"
pdf
owner:
ELBOMBARDO - (no access) - MKSAP_17.pdf, p2642
Summary
| status | not read | | reprioritisations | |
|---|
| last reprioritisation on | | | suggested re-reading day | |
|---|
| started reading on | | | finished reading on | |
|---|
Details